Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bismuth Quadruple vs Standard Triple Therapy for H. pylori Eradication
NCT02557932Phase 3Completed
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Sep 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bismuth subsalicylate, tetracycline, metronidazole, lansoprazole in Helicobacter pylori infection, sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Sep 2015; status: completed.
02
Drugs
bismuth subsalicylatetetracyclinemetronidazolelansoprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02557932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02557932.